(Q83161837)
Statements
Trough infliximab concentrations predict efficacy and sustained control of disease activity in rheumatoid arthritis (English)
Denis Mulleman
Delphine Chu Miow Lin
Emilie Ducourau
David Ternant
Charlotte Magdelaine-Beuzelin
Jean-Pierre Valat
Philippe Goupille